Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Celiac Disease Epidemiology and Market Insights Analysis and Forecasts 2023

Thursday, November 17, 2016 7:44
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Publisher’s “Celiac Disease (CD)- Market Insights, Epidemiology and Market Forecast-2023″ report provides an overview of the disease and global market size of the Celiac Disease for the 6MM (United States and EU5 countries (France, Germany, Italy, Spain and UK)). It also includes global historical and forecasted epidemiological data for the diagnosed prevalent cases of Celiac Disease from 2013-2023.
Celiac disease is a genetic autoimmune disease where the indigestion of gluten leads to damage in the small intestine. The number of ways celiac disease can affect patients, combined with a lack of training in medical schools and primary care residency programs, contributes to the poor diagnosis rate. Currently it is estimated that 80% of the celiac disease population remains undiagnosed. Prevalence in Western Europe and in the United States ranges between 1 in 250 and 1 in 133. It is higher in relatives of people with celiac disease. Women are affected more commonly than men, but there is no age predilection. Publisher forecasts predict that the total prevalent cases of Celiac Disease is expected to accentuate up to 4.69 Million by 2023 at a Compound Annual Growth Rate (CAGR) of 0.46% from 2013-2023 while the diagnosed prevalent population of Celiac Disease in the 6MM shall grow at a CAGR of 0.15% for the forecast period (2013-2023).
There is no targeted therapy approved for celiac disease. The current standard of care treatment involves a gluten free diet (GFD). Steroids and immunosuppressants are used to reduce symptoms in severe cases. Owing to the expected launch of Larazotide Acetate (Innovate Pharmaceuticals) in 2021 followed by the launch of Latiglutenase (ImmunogenX/Abbvie) in 2023, shall lead to a hike in the otherwise stable, worldwide market size of celiac disease. Publisher estimates suggest that the global market size is expected to grow at a CAGR of 19% from 2013-2023.

 

For more information about this report: http://www.reportsweb.com/celiac-disease-cd-market-insights-epidemiology-and-market-forecast-2023

 

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Scope

- Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.

- It focuses on the detailed historical and forecasted number of total prevalent cases as well as diagnosed prevalent cases of Celiac Disease for 6MM from 2013-2023.

- The Report also includes historical and forecasted Market size of Celiac Disease for 6MM from 2013 to 2023.

- It provides the information of available marketed therapies, including off-label biologics, patent and exclusivity details.

- The report also focuses on the details of pipeline drugs in the pivotal stage of development including their SWOT Analysis and expected launch date, which shall help to predict the impact of those drugs on the market size in the near future.

 

Table Of Content:-

Report Introduction
Celiac Disease Market Size Overview at a Glance
Worldwide Market Size of Celiac Disease in 2013
Worldwide Market Size of Celiac Disease in 2023
Celiac Disease Overview
Celiac Disease Types
Non-Responsive or Refractory CD
Etiology
Symptoms
Diagnosis
Disease Management
Disease Treatment
Treatment of Celiac Disease
Treatment of Non-Responsive or Refractory Celiac Disease (RCD)
Current Unmet Medical Needs
Epidemiology Parameters
 

Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001426085/sample

 

Iceberg Model
Genetic Predisposition
Epidemiology &Patient Population
United States
Diagnosed Prevalent Cases of Celiac Disease in United States (2013-2023)
EU5 Countries
France
Diagnosed Prevalent Cases of Celiac Disease in France (2013-2023)
Germany
Diagnosed Prevalent Cases of Celiac Disease in Germany (2013-2023)
Italy
Diagnosed Prevalent Cases of Celiac Disease in Italy (2013-2023)
Spain
Diagnosed Prevalent Cases of Celiac Disease in Spain (2013-2023)
United Kingdom
Diagnosed Prevalent Cases of Celiac Disease in United Kingdom (2013-2023)
Emerging Phase III Therapies
Larazotide acetate
Product Description
Regulatory Milestones
Clinical Development
Clinical Pipeline Activity
Clinical Trial by Phase
SWOT Analysis
Latiglutenase
Product Description
Regulatory Milestones
Clinical Development
Clinical Pipeline Activity
Clinical Trial by Phase
SWOT Analysis
AMG 714
Product Description
Regulatory Milestones
Clinical Development
Clinical Pipeline Activity
Clinical Trial by Phase
SWOT Analysis
Celiac Disease Market Size
Global Market Size of Celiac Disease (2013-2023)
Region-Wise Market size of Celiac Disease (2013-2023)
United States
Total Market Size of Celiac Disease (2013-2023)
European Five Countries
Italy
Total Market Size of Celiac Disease (2013-2023)
Germany
Total Market Size of Celiac Disease (2013-2023)
France
Total Market Size of Celiac Disease(2013-2023)
United Kingdom
Total Market Size of Celiac Disease (2013-2023)
Spain
Total Market Size of Celiac Disease (2013-2023)
Japan- Epidemiology and Market Size
Market Drivers
Market Barriers
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

 

Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001426085/buying

 

Contact Us:

Call: +1-646-491-9876
Email: sales@reportsweb.com

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.